What is United Therapeutics Corp's Market Cap?

United Therapeutics Corp's Market Cap is $21.4B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Enterprise Value?

United Therapeutics Corp's Enterprise Value is $18.7B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Trailing P/E?

United Therapeutics Corp's Trailing P/E is 16.3×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Price / Sales?

United Therapeutics Corp's Price / Sales is 6.8×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's EV / Revenue?

United Therapeutics Corp's EV / Revenue is 5.9×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's EV / EBITDA?

United Therapeutics Corp's EV / EBITDA is 12.5×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Revenue (TTM)?

United Therapeutics Corp's Revenue (TTM) is $3.2B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Net Income (TTM)?

United Therapeutics Corp's Net Income (TTM) is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's EBITDA?

United Therapeutics Corp's EBITDA is $1.5B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Diluted EPS (TTM)?

United Therapeutics Corp's Diluted EPS (TTM) is 30.56, based on as-reported figures from SEC (XBRL) filings.

United Therapeutics Corp (UTHR) Financial Statements

United Therapeutics Corp

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S8RV10

XNAS · usd

497.97▲ 0.00 (0.00%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close497.97

Day's Range479.71 – 505.00

52-Week Range388.73 – 612.29

Volume618.3K

Avg Volume503.0K

Share Statistics

Shares Outstanding

Employees1,400

ExchangeXNAS

Listed1999-06-17

Share count as of July 29, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about United Therapeutics Corp (UTHR)

What is United Therapeutics Corp's Market Cap?: United Therapeutics Corp's Market Cap is $21.4B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Enterprise Value?: United Therapeutics Corp's Enterprise Value is $18.7B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Trailing P/E?: United Therapeutics Corp's Trailing P/E is 16.3×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Price / Sales?: United Therapeutics Corp's Price / Sales is 6.8×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's EV / Revenue?: United Therapeutics Corp's EV / Revenue is 5.9×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's EV / EBITDA?: United Therapeutics Corp's EV / EBITDA is 12.5×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Revenue (TTM)?: United Therapeutics Corp's Revenue (TTM) is $3.2B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Net Income (TTM)?: United Therapeutics Corp's Net Income (TTM) is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's EBITDA?: United Therapeutics Corp's EBITDA is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Diluted EPS (TTM)?: United Therapeutics Corp's Diluted EPS (TTM) is 30.56, based on as-reported figures from SEC (XBRL) filings.